JP2017511155A5 - - Google Patents

Download PDF

Info

Publication number
JP2017511155A5
JP2017511155A5 JP2017505732A JP2017505732A JP2017511155A5 JP 2017511155 A5 JP2017511155 A5 JP 2017511155A5 JP 2017505732 A JP2017505732 A JP 2017505732A JP 2017505732 A JP2017505732 A JP 2017505732A JP 2017511155 A5 JP2017511155 A5 JP 2017511155A5
Authority
JP
Japan
Prior art keywords
cas
bacterium
crrna
pam
deletion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017505732A
Other languages
English (en)
Japanese (ja)
Other versions
JP6621464B2 (ja
JP2017511155A (ja
Filing date
Publication date
Priority claimed from GBGB1406968.6A external-priority patent/GB201406968D0/en
Application filed filed Critical
Publication of JP2017511155A publication Critical patent/JP2017511155A/ja
Publication of JP2017511155A5 publication Critical patent/JP2017511155A5/ja
Application granted granted Critical
Publication of JP6621464B2 publication Critical patent/JP6621464B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017505732A 2014-04-17 2015-04-16 欠失突然変異 Expired - Fee Related JP6621464B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1406968.6 2014-04-17
GBGB1406968.6A GB201406968D0 (en) 2014-04-17 2014-04-17 Deletion mutants
PCT/GB2015/051152 WO2015159086A1 (en) 2014-04-17 2015-04-16 Deletion mutations

Publications (3)

Publication Number Publication Date
JP2017511155A JP2017511155A (ja) 2017-04-20
JP2017511155A5 true JP2017511155A5 (OSRAM) 2018-05-31
JP6621464B2 JP6621464B2 (ja) 2019-12-18

Family

ID=50928940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017505732A Expired - Fee Related JP6621464B2 (ja) 2014-04-17 2015-04-16 欠失突然変異

Country Status (9)

Country Link
US (1) US10550396B2 (OSRAM)
EP (1) EP3132035B8 (OSRAM)
JP (1) JP6621464B2 (OSRAM)
KR (1) KR20170020320A (OSRAM)
CN (1) CN106460001A (OSRAM)
BR (1) BR112016023559A2 (OSRAM)
CA (1) CA2945572A1 (OSRAM)
GB (4) GB201406968D0 (OSRAM)
WO (1) WO2015159086A1 (OSRAM)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6261500B2 (ja) 2011-07-22 2018-01-17 プレジデント アンド フェローズ オブ ハーバード カレッジ ヌクレアーゼ切断特異性の評価および改善
RS62263B1 (sr) 2013-04-16 2021-09-30 Regeneron Pharma Ciljana modifikacija genoma pacova
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
WO2015066119A1 (en) 2013-10-30 2015-05-07 North Carolina State University Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
PT3066201T (pt) 2013-11-07 2018-06-04 Massachusetts Inst Technology Métodos e composições relacionadas com crispr com arng reguladores
RU2725520C2 (ru) 2013-12-11 2020-07-02 Регенерон Фармасьютикалс, Инк. Способы и композиции для направленной модификации генома
US9068179B1 (en) 2013-12-12 2015-06-30 President And Fellows Of Harvard College Methods for correcting presenilin point mutations
US10787654B2 (en) 2014-01-24 2020-09-29 North Carolina State University Methods and compositions for sequence guiding Cas9 targeting
CA2938456C (en) 2014-02-11 2022-06-21 The Regents Of The University Of Colorado, A Body Corporate Crispr enabled multiplexed genome engineering
US11439712B2 (en) 2014-04-08 2022-09-13 North Carolina State University Methods and compositions for RNA-directed repression of transcription using CRISPR-associated genes
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
WO2016033298A1 (en) 2014-08-28 2016-03-03 North Carolina State University Novel cas9 proteins and guiding features for dna targeting and genome editing
IL301900A (en) 2014-11-21 2023-06-01 Regeneron Pharma Methods and compositions for targeted genetic modification using paired guide rnas
NZ738068A (en) 2015-05-06 2019-07-26 Snipr Tech Ltd Altering microbial populations & modifying microbiota
CN108026536A (zh) 2015-05-29 2018-05-11 北卡罗来纳州立大学 使用crispr核酸筛选细菌、古细菌、藻类和酵母的方法
EP4299754A3 (en) 2015-06-15 2024-03-20 North Carolina State University Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials
US11286480B2 (en) 2015-09-28 2022-03-29 North Carolina State University Methods and compositions for sequence specific antimicrobials
EP3365356B1 (en) 2015-10-23 2023-06-28 President and Fellows of Harvard College Nucleobase editors and uses thereof
WO2017112620A1 (en) 2015-12-22 2017-06-29 North Carolina State University Methods and compositions for delivery of crispr based antimicrobials
CA3030565A1 (en) * 2016-05-01 2017-11-09 Neemo Inc Harnessing heterologous and endogenous crispr-cas machineries for efficient markerless genome editing in clostridium
JP7324583B2 (ja) 2016-05-20 2023-08-10 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 複数のガイドｒｎａを使用して免疫寛容を破綻させるための方法
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
ES2915562T3 (es) 2016-06-24 2022-06-23 Univ Colorado Regents Métodos para generar bibliotecas combinatorias con código de barras
JP7231935B2 (ja) 2016-08-03 2023-03-08 プレジデント アンド フェローズ オブ ハーバード カレッジ アデノシン核酸塩基編集因子およびそれらの使用
EP3497214B1 (en) 2016-08-09 2023-06-28 President and Fellows of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
EP3526320A1 (en) 2016-10-14 2019-08-21 President and Fellows of Harvard College Aav delivery of nucleobase editors
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165631A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Cancer vaccine
KR20190127797A (ko) 2017-03-10 2019-11-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 시토신에서 구아닌으로의 염기 편집제
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
US10011849B1 (en) 2017-06-23 2018-07-03 Inscripta, Inc. Nucleic acid-guided nucleases
US9982279B1 (en) 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
GB201712733D0 (en) 2017-08-08 2017-09-20 Snipr Tech Ltd Methods & cells
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
CN111757937A (zh) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 腺苷碱基编辑器的用途
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
WO2020072254A1 (en) 2018-10-01 2020-04-09 North Carolina State University Recombinant type i crispr-cas system and uses thereof for killing target cells
US10711267B2 (en) 2018-10-01 2020-07-14 North Carolina State University Recombinant type I CRISPR-Cas system
WO2020072253A1 (en) 2018-10-01 2020-04-09 North Carolina State University Recombinant type i crispr-cas system and uses thereof for screening for variant cells
US12264313B2 (en) 2018-10-01 2025-04-01 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for genome modification and alteration of expression
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
US12281338B2 (en) 2018-10-29 2025-04-22 The Broad Institute, Inc. Nucleobase editors comprising GeoCas9 and uses thereof
WO2020154500A1 (en) 2019-01-23 2020-07-30 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
US11142751B2 (en) 2019-03-07 2021-10-12 Auburn University CRISPR-cas system for Clostridium genome engineering and recombinant strains produced thereof
MX2021011426A (es) 2019-03-19 2022-03-11 Broad Inst Inc Metodos y composiciones para editar secuencias de nucleótidos.
EP3956349A1 (en) 2019-04-17 2022-02-23 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
FR3096373B1 (fr) * 2019-05-24 2024-09-13 Ifp Energies Now Outil genetique optimisé pour modifier les bacteries
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
MX2022014008A (es) 2020-05-08 2023-02-09 Broad Inst Inc Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO323345B1 (no) 2002-01-07 2007-04-02 Norwegian Inst Of Fisheries An Forbedring av fiskeprodukter og fôr
GB0612301D0 (en) 2006-06-21 2006-08-02 Morvus Technology Ltd DNA molecules and methods
BRPI0622182B1 (pt) 2006-10-03 2018-07-31 Metabolic Explorer Processo para a substituição de uma sequência de DNA alvo através de recombinação homóloga em Clostridia, cepa recombinante de Clostridium e vetor para a substituição de uma sequência de DNA alvo por recombinação homóloga em Clostridia
US20110119779A1 (en) 2007-12-10 2011-05-19 Aliva Biopharmaceuticals, Inc. Methods for sequential replacement of targeted region by homologous recombination
GB0802842D0 (en) 2008-02-15 2008-03-26 Univ Nottingham Synthetic operon construction in clostridia
WO2009137778A2 (en) 2008-05-08 2009-11-12 Northwestern University Methods and compositions for genetically engineering clostridia species
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
EP2425018A4 (en) 2009-04-30 2013-06-05 Univ Columbia IN VIVO CONSTRUCTION OF DNA BY HOMOLOGOUS RECOMBINATION
WO2013133882A2 (en) * 2011-12-16 2013-09-12 University Of Delaware Recombinant clostridium organism and method for isolation of double-crossover allelic exchange mutants
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
WO2013141680A1 (en) 2012-03-20 2013-09-26 Vilnius University RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
CA2894668A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Crispr-cas systems and methods for altering expression of gene products in eukaryotic cells
US10612043B2 (en) * 2013-03-09 2020-04-07 Agilent Technologies, Inc. Methods of in vivo engineering of large sequences using multiple CRISPR/cas selections of recombineering events
US20160122774A1 (en) 2013-05-29 2016-05-05 Cellectis A method for producing precise dna cleavage using cas9 nickase activity
WO2015040402A1 (en) 2013-09-18 2015-03-26 Kymab Limited Methods. cells & organisms
CA2938456C (en) 2014-02-11 2022-06-21 The Regents Of The University Of Colorado, A Body Corporate Crispr enabled multiplexed genome engineering

Similar Documents

Publication Publication Date Title
JP2017511155A5 (OSRAM)
JP2017511156A5 (OSRAM)
Song et al. CRISPR-Cas9D10A nickase-assisted genome editing in Lactobacillus casei
JP6621464B2 (ja) 欠失突然変異
McAllister et al. CRISPR genome editing systems in the genus Clostridium: a timely advancement
Huang et al. Development of a RecE/T‐assisted CRISPR–Cas9 toolbox for Lactobacillus
Li et al. CRISPR‐based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii
Wang et al. Genome editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 system
Wang et al. Markerless chromosomal gene deletion in Clostridium beijerinckii using CRISPR/Cas9 system
US9988637B2 (en) Cas9 plasmid, genome editing system and method of Escherichia coli
Cartman et al. A m ariner-Based Transposon System for In Vivo Random Mutagenesis of Clostridium difficile
Ehsaan et al. Mutant generation by allelic exchange and genome resequencing of the biobutanol organism Clostridium acetobutylicum ATCC 824
CN101528930B (zh) 用于在梭菌属中进行染色体整合和dna序列替换的方法
EP3778867A1 (en) Phage resistant lactic acid bacteria
US20190367947A1 (en) Optimized genetic tool for modifying clostridium bacteria
JP6473510B2 (ja) ビブリオで汎用される遺伝子ノックアウト用の自殺ベクターおよびその利用
Zhang et al. Markerless genome editing in Clostridium beijerinckii using the CRISPR-Cpf1 system
Pyne et al. Expansion of the genetic toolkit for metabolic engineering of Clostridium pasteurianum: chromosomal gene disruption of the endogenous CpaAI restriction enzyme
JP2011512153A5 (OSRAM)
JP7555599B2 (ja) 遺伝子的に改変されたｃｌｏｓｔｒｉｄｉｕｍ細菌の、調製およびその使用。
Brumwell et al. Slicer: A seamless gene deletion method for Deinococcus radiodurans
CN105483034A (zh) 一种转换酵母交配型的方法
JP7661241B2 (ja) 細菌を改変するための最適化された遺伝子ツール
Narajczyk et al. Switch from θ to σ replication of bacteriophage λ DNA: factors involved in the process and a model for its regulation
Vento et al. Genome editing with Cas9 in lactobacilli